SCHEMBL1885511

SCHEMBL1885511

Cc1nc(NC(=O)n2ccnc2)sc1-c1ccncc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 11/20 0.47
PIK3CA P42336 10/20 0.47
PIK3CG P48736 10/20 0.47
PIK3CB P42338 9/20 0.47
XIAP P98170 1/20 0.47
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
ALDH1A1 P00352 1/20 0.43
TSHR P16473 1/20 0.43
CLK1 P49759 1/20 0.43
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42
PI4KB Q9UBF8 1/20 0.41
ADORA3 P0DMS8 3/20 0.41
ADORA2B P29275 2/20 0.40
CHRM5 P08912 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2326527 0.89 PIK3CD (0.65) PIK3CDPIK3CAPIK3CGPIK3CBXIAP
SCHEMBL1882046 0.87 PIK3CA (0.43) PIK3CDPIK3CAPIK3CGPIK3CBXIAP
SCHEMBL1786172 0.87 PIK3CD (0.65) PIK3CDPIK3CAPIK3CGPIK3CBXIAP
SCHEMBL12991700 0.86 PIK3CG (0.51) PIK3CDPIK3CAPIK3CGPIK3CBXIAP
SCHEMBL1889405 0.86 PIK3CA (0.50) PIK3CDPIK3CAPIK3CGPIK3CBXIAP
SCHEMBL24023246 0.84 PIK3CA (0.48) PIK3CDPIK3CAPIK3CGPIK3CBXIAP
SCHEMBL571452 0.84 PIK3CA (0.69) PIK3CDPIK3CAPIK3CGPIK3CBPI4KB
SCHEMBL13149663 0.84 PIK3CD (0.72) PIK3CDPIK3CAPIK3CGPIK3CBXIAP
SCHEMBL13469237 0.84 PIK3CA (0.48) PIK3CDPIK3CAPIK3CGPIK3CBPI4KB
SCHEMBL29089052 0.82 PIK3CG (0.39) PIK3CDPIK3CAPIK3CGPIK3CBXIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110105535-A1 INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE NOVARTIS AG 2011-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110105535-A1 INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE PIK3CA, PIK3CD, PIP4K2C PIK3CD 2/4885PIK3CA 1/4885PIK3CG 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.